EGFR-TKI monotherapy has been utilized for EGFR mutant lung cancer, and EGF monoclonal antibodies, together with chemotherapy, have been used for breast cancer, gastric cancer, and colon cancer, among others. This evidence concerns the gene EGFR and lung cancer.